Featured Research

from universities, journals, and other organizations

Hydroxyethyl starch has direct harmful effects on kidney cells, lab study finds

Date:
July 11, 2014
Source:
Wolters Kluwer Health
Summary:
The increased risk of kidney injury related to the use of hydroxyethyl starch in resuscitation fluids reflects the mass of HES molecules, according to a report. Hydroxyethyl starch is a starch derivative that has been widely used for fluid resuscitation with volume expansion for critically ill or injured patients in shock. A growing body of evidence suggests that HES solutions may have harmful effects, including an increased risk of kidney injury and death.

The increased risk of kidney injury related to the use of hydroxyethyl starch (HES) in resuscitation fluids reflects the mass of HES molecules, according to a report in Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).

The "total mass of HES molecules" explains the harmful effect of HES on cultured human renal proximal tubule cells (PTCs), concludes the laboratory study by Dr Christian Wunder and colleagues of University Hospital Würzburg, Austria. Other factors -- such as differences in the origin or molecular weight of HES solutions -- appear to play little or no role in cellular-level toxicity of HES.

What Factors Affect Toxic Effects of HES on Kidney Cells?

Hydroxyethyl starch is a starch derivative that has been widely used for fluid resuscitation with volume expansion for critically ill or injured patients in shock. A growing body of evidence suggests that HES solutions may have harmful effects, including an increased risk of kidney injury and death.

In previous studies, Dr Wunder and colleagues found that HES caused impaired kidney function in animals with sepsis (severe infection). Those studies showed that HES was localized mainly in the kidney PTCs. The researchers performed a series of in-depth follow-up experiments to look at factors influencing the toxic effects of HES on cultured human PTCs.

Most of the factors assessed had no major influence on reductions in cell viability caused by HES. Cellular toxicity was unrelated to the type of "carrier" solution used in the cell cultures, the use of HES made from different origins (potato versus corn starch), or the time cells spent in culture with HES.

The toxic effects were also similar for HES solutions of different molecular weights. That's an important finding, as newer low-molecular weight HES solutions were thought to be safer than previous products. There was also no evidence that the toxic effects of HES were related to the presence of inflammation.

Instead, the only significant factor was the total mass of HES molecules. The effect was dose-dependent: the greater the molecular mass, the greater the evidence of cell toxicity. The toxic effects started very soon after PTCs were exposed to HEC, and further increased at higher doses.

There is a long history of debate and confusion over potential harmful effects of HES solutions used for resuscitation. Recent studies have linked HES to reduced kidney function in patients with sepsis. Last year, both the US Food and Drug Administration and the European Medicines Agency issued statements that HES solutions should not be used in critically ill patients.

The new study suggests that the molecular mass of HES is the major factor responsible for damage to kidney cells. Other factors have no significant influence -- even with new low-molecular weight HES solutions, cellular-level toxic effects appear just as likely, once the total mass of HES molecules is taken into account.

Although the study was performed in the laboratory on cultured kidney cells, the PTC toxicity caused by HES appears consistent with the risks of kidney damage and death observed in critically ill patients. Dr Wunder and coauthors conclude, "Our data show that HES itself has a negative impact on renal PTC, which should be considered when used clinically."


Story Source:

The above story is based on materials provided by Wolters Kluwer Health. Note: Materials may be edited for content and length.


Journal Reference:

  1. Raphael R. Bruno, Winfried Neuhaus, Norbert Roewer, Christian Wunder, Martin A. Schick. Molecular Size and Origin Do Not Influence the Harmful Side Effects of Hydroxyethylstarch on Human Proximal Tubule Cells (HK-2) In Vitro. Anesthesia & Analgesia, 2014; 1 DOI: 10.1213/ANE.0000000000000325

Cite This Page:

Wolters Kluwer Health. "Hydroxyethyl starch has direct harmful effects on kidney cells, lab study finds." ScienceDaily. ScienceDaily, 11 July 2014. <www.sciencedaily.com/releases/2014/07/140711132837.htm>.
Wolters Kluwer Health. (2014, July 11). Hydroxyethyl starch has direct harmful effects on kidney cells, lab study finds. ScienceDaily. Retrieved October 22, 2014 from www.sciencedaily.com/releases/2014/07/140711132837.htm
Wolters Kluwer Health. "Hydroxyethyl starch has direct harmful effects on kidney cells, lab study finds." ScienceDaily. www.sciencedaily.com/releases/2014/07/140711132837.htm (accessed October 22, 2014).

Share This



More Health & Medicine News

Wednesday, October 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

CDC Revamps Ebola Guidelines After Criticism

CDC Revamps Ebola Guidelines After Criticism

Newsy (Oct. 21, 2014) — The Centers for Disease Control and Prevention have issued new protocols for healthcare workers interacting with Ebola patients. Video provided by Newsy
Powered by NewsLook.com
WHO: Ebola Vaccine Trials to Start a in January

WHO: Ebola Vaccine Trials to Start a in January

AP (Oct. 21, 2014) — Tens of thousands of doses of experimental Ebola vaccines could be available for "real-world" testing in West Africa as soon as January as long as they are deemed safe in soon to start trials, the World Health Organization said Tuesday. (Oct. 21) Video provided by AP
Powered by NewsLook.com
First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

Newsy (Oct. 21, 2014) — A medical team has for the first time given a man the ability to walk again after transplanting cells from his brain onto his severed spinal cord. Video provided by Newsy
Powered by NewsLook.com
CDC Issues New Ebola Guidelines for Health Workers

CDC Issues New Ebola Guidelines for Health Workers

Reuters - US Online Video (Oct. 21, 2014) — The U.S. Centers for Disease Control and Prevention has set up new guidelines for health workers taking care of patients infected with Ebola. Linda So reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins